Status:
UNKNOWN
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut
Lead Sponsor:
Muhammad Ameen Abdelrady Abdelaziz
Conditions:
CKD
NAFLD
Eligibility:
All Genders
18-80 years
Brief Summary
The goal of this observational study is to detect the prevalence of NAFLD in CKD patients The main question\[s\] it aims to answer are: * \[question 1\] prevalence of NAFLD in CKD patients. * \[ques...
Detailed Description
The goal of this observational study is to detect the prevalence of NAFLD in CKD patients The main question\[s\] it aims to answer are: * \[question 1\] prevalence of NAFLD in CKD patients. * \[ques...
Eligibility Criteria
Inclusion
- CKD patients
Exclusion
- HCV and HBV Positive patients
- Alcoholics
- patient on Hemodialysis
- patients with wilson disease
- patients with alpha one antitrypsin deficiency
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06009250
Start Date
December 1 2023
End Date
December 1 2024
Last Update
August 24 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.